Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of TAS-102 in Patients with Metastatic Colorectal Cancer; the HGCSG1503 Study

ABSTRACT: Primary outcome(s): Overall Survival

DISEASE(S): Colorectal Cancer

PROVIDER: 2635827 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR